Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuyuan Fang is a Traditional Chinese Medicine (TCM) herbal formula primarily utilized in China for the treatment of cancer-related fatigue (CRF) and to support recovery in patients undergoing chemotherapy or surgery for various malignancies, including lung and colorectal cancers. The formula is constructed based on TCM principles to tonify 'Qi' and nourish 'Blood,' addressing the systemic depletion often observed in oncology patients. It typically comprises a complex mixture of botanical extracts, including *Astragalus membranaceus* (Huangqi), *Panax ginseng* (Renshen), and *Angelica sinensis* (Danggui). Pharmacological investigations suggest that Fuyuan Fang exerts its therapeutic effects through immunomodulation—specifically by balancing T-lymphocyte subsets—and by suppressing systemic inflammation through the reduction of pro-inflammatory cytokines like IL-6 and TNF-alpha. It is commonly prepared as an oral decoction or in a standardized granule form for clinical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuyuan fang.